The Asia Pacific Negative Pressure Wound Therapy Market would witness market growth of 7.1% CAGR during the forecast period (2023-2030).
NPWT has proven highly effective in managing chronic wounds, including diabetic ulcers, venous ulcers, and pressure ulcers. The therapy promotes angiogenesis and accelerates granulation tissue formation, addressing the challenges of slow-healing chronic wounds. Following various surgical procedures, patients are at risk of complications like infections and delayed wound healing. NPWT is extensively used in post-surgical wound care to enhance tissue perfusion, reduce edema, and expedite healing. It is applied in surgeries ranging from orthopedic to abdominal and cardiovascular surgeries.
NPWT plays a crucial role in the management of traumatic injuries and acute wounds, such as lacerations, abrasions, and crush injuries. The therapy assists in removing excess exudate, promotes tissue regeneration, and lowers the risk of infection, contributing to optimal wound healing outcomes. Burn wounds pose unique challenges in terms of tissue damage and infection risk. NPWT has emerged as a valuable tool in burn wound therapy, creating a controlled environment that supports healing, reduces scarring, and minimizes the need for grafting. It is particularly beneficial in managing partial-thickness and full-thickness burn injuries.
As per Invest India, in FY17, the hospital industry in India was worth $ 61.79 billion, projected to reach $ 132 billion by 2023. India has witnessed a notable increase in hospitals, ranging from small clinics to large multispecialty hospitals. Additionally, by 2045, the United Nations estimates that approximately 450 million individuals in China will be 60 or older. Advances in healthcare, improved living conditions, and enhanced medical services have increased life expectancy in China. Thus, due to the above-mentioned factors, the market will grow significantly in this region.
The China market dominated the Asia Pacific Negative Pressure Wound Therapy Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $258.7 million by 2030. The Japan market is registering a CAGR of 6.4% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 7.8% during (2023 - 2030).
Based on End-Use, the market is segmented into Hospitals, Homecare, and Others. Based on Product, the market is segmented into Conventional NPWT, and Single-use NPWT. Based on Type, the market is segmented into Pressure Ulcers, Diabetic Foot Ulcers, Venous Leg Ulcers, Burn Wounds, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
NPWT has proven highly effective in managing chronic wounds, including diabetic ulcers, venous ulcers, and pressure ulcers. The therapy promotes angiogenesis and accelerates granulation tissue formation, addressing the challenges of slow-healing chronic wounds. Following various surgical procedures, patients are at risk of complications like infections and delayed wound healing. NPWT is extensively used in post-surgical wound care to enhance tissue perfusion, reduce edema, and expedite healing. It is applied in surgeries ranging from orthopedic to abdominal and cardiovascular surgeries.
NPWT plays a crucial role in the management of traumatic injuries and acute wounds, such as lacerations, abrasions, and crush injuries. The therapy assists in removing excess exudate, promotes tissue regeneration, and lowers the risk of infection, contributing to optimal wound healing outcomes. Burn wounds pose unique challenges in terms of tissue damage and infection risk. NPWT has emerged as a valuable tool in burn wound therapy, creating a controlled environment that supports healing, reduces scarring, and minimizes the need for grafting. It is particularly beneficial in managing partial-thickness and full-thickness burn injuries.
As per Invest India, in FY17, the hospital industry in India was worth $ 61.79 billion, projected to reach $ 132 billion by 2023. India has witnessed a notable increase in hospitals, ranging from small clinics to large multispecialty hospitals. Additionally, by 2045, the United Nations estimates that approximately 450 million individuals in China will be 60 or older. Advances in healthcare, improved living conditions, and enhanced medical services have increased life expectancy in China. Thus, due to the above-mentioned factors, the market will grow significantly in this region.
The China market dominated the Asia Pacific Negative Pressure Wound Therapy Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $258.7 million by 2030. The Japan market is registering a CAGR of 6.4% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 7.8% during (2023 - 2030).
Based on End-Use, the market is segmented into Hospitals, Homecare, and Others. Based on Product, the market is segmented into Conventional NPWT, and Single-use NPWT. Based on Type, the market is segmented into Pressure Ulcers, Diabetic Foot Ulcers, Venous Leg Ulcers, Burn Wounds, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- 3M Company
- Talley Group Ltd. (Direct Healthcare Group)
- Smith & Nephew PLC
- Molnlycke Health Care AB
- DeRoyal Industries, Inc.
- ConvaTec Group PLC
- Cardinal Health, Inc.
- HARTMANN Group (Paul Hartmann AG)
- Cork Medical, LLC
Market Report Segmentation
By End-Use- Hospitals
- Homecare
- Others
- Conventional NPWT
- Single-use NPWT
- Pressure Ulcers
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Burn Wounds
- Others
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Asia Pacific Negative Pressure Wound Therapy Market, By End-Use
Chapter 5. Asia Pacific Negative Pressure Wound Therapy Market, By Product
Chapter 6. Asia Pacific Negative Pressure Wound Therapy Market, By Type
Chapter 7. Asia Pacific Negative Pressure Wound Therapy Market, By Country
Chapter 8. Company Profiles
Companies Mentioned
- 3M Company
- Talley Group Ltd. (Direct Healthcare Group)
- Smith & Nephew PLC
- Molnlycke Health Care AB
- DeRoyal Industries, Inc.
- ConvaTec Group PLC
- Cardinal Health, Inc.
- HARTMANN Group (Paul Hartmann AG)
- Cork Medical, LLC
Methodology
LOADING...